Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139


Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.

Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler GB Jr.

J Clin Endocrinol Metab. 2003 Sep;88(9):4214-20.


Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.

Winer KK, Sinaii N, Reynolds J, Peterson D, Dowdy K, Cutler GB Jr.

J Clin Endocrinol Metab. 2010 Jun;95(6):2680-8. doi: 10.1210/jc.2009-2464. Epub 2010 Apr 14.


Transient Increased Calcium and Calcitriol Requirements After Discontinuation of Human Synthetic Parathyroid Hormone 1-34 (hPTH 1-34) Replacement Therapy in Hypoparathyroidism.

Gafni RI, Guthrie LC, Kelly MH, Brillante BA, Christie CM, Reynolds JC, Yovetich NA, James R, Collins MT.

J Bone Miner Res. 2015 Nov;30(11):2112-8. doi: 10.1002/jbmr.2555. Epub 2015 Aug 3.


A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism.

Winer KK, Yanovski JA, Sarani B, Cutler GB Jr.

J Clin Endocrinol Metab. 1998 Oct;83(10):3480-6.


Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism.

Winer KK, Sinaii N, Peterson D, Sainz B Jr, Cutler GB Jr.

J Clin Endocrinol Metab. 2008 Sep;93(9):3389-95. doi: 10.1210/jc.2007-2552. Epub 2008 May 20.


Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.

Winer KK, Yanovski JA, Cutler GB Jr.

JAMA. 1996 Aug 28;276(8):631-6.


Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.

Clarke BL, Kay Berg J, Fox J, Cyran JA, Lagast H.

Clin Ther. 2014 May;36(5):722-36. doi: 10.1016/j.clinthera.2014.04.001. Epub 2014 May 5.


PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.

Santonati A, Palermo A, Maddaloni E, Bosco D, Spada A, Grimaldi F, Raggiunti B, Volpe R, Manfrini S, Vescini F; Hypoparathyroidism AME Group.

J Clin Endocrinol Metab. 2015 Sep;100(9):3590-7. doi: 10.1210/jc.2015-1855. Epub 2015 Jul 21.


Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism.

Winer KK, Zhang B, Shrader JA, Peterson D, Smith M, Albert PS, Cutler GB Jr.

J Clin Endocrinol Metab. 2012 Feb;97(2):391-9. doi: 10.1210/jc.2011-1908. Epub 2011 Nov 16. Erratum in: J Clin Endocrinol Metab. 2015 Jul;100(7):2800.


Sporadic hypoparathyroidism treated with teriparatide: a case report and literature review.

Angelopoulos NG, Goula A, Tolis G.

Exp Clin Endocrinol Diabetes. 2007 Jan;115(1):50-4. Review.


Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: a randomized prospective multicentre trial.

Hayashi M, Tsuchiya Y, Itaya Y, Takenaka T, Kobayashi K, Yoshizawa M, Nakamura R, Monkawa T, Ichihara A.

Nephrol Dial Transplant. 2004 Aug;19(8):2067-73. Epub 2004 Jun 8.


Effect of parathyroid hormone administration in a patient with severe hypoparathyroidism caused by gain-of-function mutation of calcium-sensing receptor.

Shiohara M, Shiozawa R, Kurata K, Matsuura H, Arai F, Yasuda T, Koike K.

Endocr J. 2006 Dec;53(6):797-802. Epub 2006 Sep 19.


Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.

Collins MT, Lindsay JR, Jain A, Kelly MH, Cutler CM, Weinstein LS, Liu J, Fedarko NS, Winer KK.

J Bone Miner Res. 2005 Nov;20(11):1944-50. Epub 2005 Jul 18.


Parathyroid Hormone Replacement Therapy in Hypoparathyroidism: A Meta-Analysis.

Liu XX, Zhu XY, Mei GH.

Horm Metab Res. 2016 Jun;48(6):377-83. doi: 10.1055/s-0042-106970. Epub 2016 Jun 2.


Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety.

Cusano NE, Rubin MR, McMahon DJ, Zhang C, Ives R, Tulley A, Sliney J Jr, Cremers SC, Bilezikian JP.

J Clin Endocrinol Metab. 2013 Jan;98(1):137-44. doi: 10.1210/jc.2012-2984. Epub 2012 Nov 15.


Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study.

Ebeling PR, Wark JD, Yeung S, Poon C, Salehi N, Nicholson GC, Kotowicz MA.

J Clin Endocrinol Metab. 2001 Sep;86(9):4098-103.


Treatment of hypocalcemia caused by hypoparathyroidism or pseudohypoparathyroidism with domestic-made calcitriol: a prospective and self-controlled clinical trial.

Wang O, Xing XP, Meng XW, Xia WB, Li M, Jiang Y, Hu YY, Liu HC.

Chin Med J (Engl). 2009 Feb 5;122(3):279-83.


Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide.

Puig-Domingo M, Díaz G, Nicolau J, Fernández C, Rueda S, Halperin I.

Eur J Endocrinol. 2008 Nov;159(5):653-7. doi: 10.1530/EJE-08-0269. Epub 2008 Aug 14.


Use of parathyroid hormone in hypoparathyroidism.

Cusano NE, Rubin MR, Irani D, Sliney J Jr, Bilezikian JP.

J Endocrinol Invest. 2013 Dec;36(11):1121-7. Review.

Supplemental Content

Support Center